Sodium Dodecyl Sulfate

serpin family C member 1 ; Homo sapiens







42 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 20211924 Replacement of Phe274 with conserved residue Tyr274 for reactive center loop expulsion in antithrombin. 2011 Jun 2
2 21297450 Protamine sulfate stimulates degradation of factor Xa and the factor Xa-antithrombin complex. 2011 Jun 1
3 17584894 Effects on coagulation of a synthetic heparan mimetic given intraperitoneally or orally. 2007 Dec 15 1
4 17879089 Comparison of planar SDS-PAGE, CGE-on-a-chip, and MALDI-TOF mass spectrometry for analysis of the enzymatic de-N-glycosylation of antithrombin III and coagulation factor IX with PNGase F. 2007 Nov 1
5 15664348 A novel matrix for high performance affinity chromatography and its application in the purification of antithrombin III. 2005 Feb 25 1
6 12907439 Heparin-induced substrate behavior of antithrombin Cambridge II. 2003 Dec 1 1
7 14532267 Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin. 2003 Dec 19 1
8 12353073 Antithrombin 'DREUX' (Lys 114Glu): a variant with complete loss of heparin affinity. 2002 Sep 1
9 11551226 The distinct roles that Gln-192 and Glu-217 of factor IX play in selectivity for macromolecular substrates and inhibitors. 2001 Sep 18 4
10 9794814 Inactivation of papain by antithrombin due to autolytic digestion: a model of serpin inactivation of cysteine proteinases. 1998 Nov 1 2
11 7606009 Iodine-mediated inactivation of lipid- and nonlipid-enveloped viruses in human antithrombin III concentrate. 1995 Jul 15 1
12 7647008 Measurement of factor Xa-antithrombin III in plasma: relationship to prothrombin activation in vivo. 1995 Jul 2
13 7730349 Kinetic characterization of the proteinase binding defect in a reactive site variant of the serpin, antithrombin. Role of the P1' residue in transition-state stabilization of antithrombin-proteinase complex formation. 1995 Apr 28 1
14 8619306 [Reactions between protease inhibitors in blood plasma and collagen]. 1995 Nov-Dec 1
15 7863481 A phenylalanine 402 to leucine mutation is responsible for a stable inactive conformation of antithrombin. 1994 Nov 1 1
16 7692967 High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein. 1993 Nov 16 1
17 8419351 Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. 1993 Jan 15 1
18 1440655 Purification and characterization of an antithrombin III inactivating enzyme from the venom of the African night adder (Causus rhombeatus). 1992 Sep 1
19 1519763 Enzyme-linked immunosorbent assay for proteolytically inactivated antithrombin-III: use of sodium dodecyl sulfate to eliminate signal due to intact antithrombin-III. 1992 May 1 5
20 1911389 Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin. 1991 Sep 2
21 2029579 Antithrombin-III-Hamilton, Ala 382 to Thr: an antithrombin-III variant that acts as a substrate but not an inhibitor of alpha-thrombin and factor Xa. 1991 May 15 5
22 2154059 The effect of human thrombomodulin on the inactivation of thrombin by human antithrombin III. 1990 Jan 1 1
23 2207328 Expression in a cell-free system of normal and variant forms of human antithrombin III. Ability to bind heparin and react with alpha-thrombin. 1990 Oct 15 2
24 2363123 Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiency. 1990 Apr 12 1
25 2752479 Synergistic effect of antithrombin III, activated protein C and heparin on the inhibition of the tissue thromboplastin-mediated coagulation. 1989 Mar 6
26 3187951 Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III Charleville. 1988 Aug 30 1
27 3606566 Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum. 1987 Apr 1 1
28 3663509 Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis. 1987 Aug 1
29 3801671 Prothrombin Tokushima: characterization of dysfunctional thrombin derived from a variant of human prothrombin. 1987 Feb 1
30 3486013 Interaction of factor XIa and antithrombin in the presence and absence of heparin. 1986 May 1
31 3512602 Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver"). 1986 Mar 4
32 3526065 Molecular analysis of urinary AT III related antigen in liver cirrhosis. 1986 Jul 21 1
33 3699029 S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin. 1986 May 2 1
34 2415521 Association of thrombin-antithrombin III complex with vitronectin in serum. 1985 Dec 15 1
35 6546700 Thrombin Metz: characterization of the dysfunctional thrombin derived from a variant of human prothrombin. 1984 Apr 1
36 7037067 Differential role of fractionated heparin in antithrombin-III proteolysis. 1982 Mar 1
37 7213342 The covalent nature of the human antithrombin III--thrombin bond. 1980 Sep 1 1
38 7426659 Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin. 1980 Sep 9 4
39 316999 Affinity chromatography in the separation of human alpha 1-antitrypsin (alpha 1-AT) and antithrombin-III (AT-III). 1979 Jun 1
40 420768 Antithrombin reactions with alpha- and gamma-thrombins. 1979 Jan 9 1
41 65284 Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration. 1977 Feb 1
42 1194266 Inhibition of human factor IXa by human antithrombin. 1975 Dec 10 1